A2AAR antagonist 4 is an orally active A2A Adenosine receptor antagonist with a Ki of 0.36 nM and a KB of 1 nM at hA2AAR. A2AAR antagonist 4 fully inhibits hA2AAR and hA2bAR at 10 µM. A2AAR antagonist 4 can be used for research of cancer, such as MC38 tiumor[1].
Molecular Weight:
367.40
Formula:
C19H21N5O3
Target:
Adenosine Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
